Immunic, Inc.

NasdaqGS:IMUX 株式レポート

時価総額：US$107.2m

Immunic マネジメント

マネジメント 基準チェック /34

Immunicの CEO はDaniel Vittで、 Apr2019年に任命され、 の在任期間は 5.58年です。 の年間総報酬は$ 1.21Mで、 48.3%給与と51.7%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.42%を直接所有しており、その価値は$ 448.48K 。経営陣と取締役会の平均在任期間はそれぞれ4.6年と4年です。

主要情報

Daniel Vitt

最高経営責任者

US$1.2m

報酬総額

CEO給与比率48.3%
CEO在任期間5.6yrs
CEOの所有権0.4%
経営陣の平均在職期間4.6yrs
取締役会の平均在任期間4yrs

経営陣の近況

Recent updates

We're Keeping An Eye On Immunic's (NASDAQ:IMUX) Cash Burn Rate

Oct 25
We're Keeping An Eye On Immunic's (NASDAQ:IMUX) Cash Burn Rate

Here's Why We're A Bit Worried About Immunic's (NASDAQ:IMUX) Cash Burn Situation

Jan 22
Here's Why We're A Bit Worried About Immunic's (NASDAQ:IMUX) Cash Burn Situation

Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely

Oct 13
Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely

Will Immunic (NASDAQ:IMUX) Spend Its Cash Wisely?

Jun 27
Will Immunic (NASDAQ:IMUX) Spend Its Cash Wisely?

Immunic sinks ~74% after hours as phase 1b psoriasis trial fails to separate from placebo

Oct 20

Immunic stock gains on $60M oversubscribed PIPE financing

Oct 10

Immunic GAAP EPS of -$0.72 in-line

Aug 04

Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely

Jul 27
Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely

Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?

Apr 13
Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?

Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?

Dec 24
Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?

Here's Why We're Watching Immunic's (NASDAQ:IMUX) Cash Burn Situation

Aug 13
Here's Why We're Watching Immunic's (NASDAQ:IMUX) Cash Burn Situation

We're Hopeful That Immunic (NASDAQ:IMUX) Will Use Its Cash Wisely

May 10
We're Hopeful That Immunic (NASDAQ:IMUX) Will Use Its Cash Wisely

Immunic EPS misses by $0.95

May 06

Immunic EPS misses by $0.07

Nov 05

Enrollment underway in Immunic's Phase 2 part of IMU-838 study in COVID-19

Nov 02

Immunic (IMUX) Investor Presentation - Slideshow

Oct 31

CEO報酬分析

Immunic の収益と比較して、Daniel Vitt の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$95m

Mar 31 2024n/an/a

-US$98m

Dec 31 2023US$1mUS$585k

-US$94m

Sep 30 2023n/an/a

-US$129m

Jun 30 2023n/an/a

-US$127m

Mar 31 2023n/an/a

-US$125m

Dec 31 2022US$3mUS$520k

-US$120m

Sep 30 2022n/an/a

-US$85m

Jun 30 2022n/an/a

-US$83m

Mar 31 2022n/an/a

-US$79m

Dec 31 2021US$2mUS$399k

-US$93m

Sep 30 2021n/an/a

-US$83m

Jun 30 2021n/an/a

-US$77m

Mar 31 2021n/an/a

-US$70m

Dec 31 2020US$1mUS$381k

-US$44m

Sep 30 2020n/an/a

-US$41m

Jun 30 2020n/an/a

-US$36m

Mar 31 2020n/an/a

-US$39m

Dec 31 2019US$2mUS$202k

-US$35m

報酬と市場: Danielの 総報酬 ($USD 1.21M ) は、 US市場 ($USD 655.65K ) の同規模の企業の平均を上回っています。

報酬と収益: Danielの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Daniel Vitt (56 yo)

5.6yrs

在職期間

US$1,211,839

報酬

Dr. Daniel Vitt, PhD has been the Chief Executive Officer of Immunic, Inc. since April 2019 and also served as its President until July 12, 2024. He is also managing director of Immunic Research GmbH in Ha...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Duane Nash
Executive Chairman5.8yrsUS$648.93k0.024%
$ 26.2k
Daniel Vitt
CEO & Director5.6yrsUS$1.21m0.42%
$ 448.5k
Glenn Whaley
Chief Financial Officer4.6yrsUS$702.21k0.028%
$ 30.4k
Andreas Muehler
Chief Medical Officer8.3yrsUS$845.29k0.36%
$ 382.9k
Jason Tardio
COO & Presidentless than a yearデータなしデータなし
Hella Kohlhof
Chief Scientific Officer7.8yrsデータなしデータなし
Jessica Breu
Head of Investor Relations & Communicationsno dataデータなしデータなし
Inderpal Singh
General Counsel3.4yrsデータなしデータなし
Patrick Walsh
Chief Business Officer3.1yrsデータなしデータなし
Werner Gladdines
Chief Development Officerless than a yearデータなしデータなし

4.6yrs

平均在職期間

54.5yo

平均年齢

経験豊富な経営陣: IMUXの経営陣は 経験豊富 であると考えられます ( 4.6年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Duane Nash
Executive Chairman5.8yrsUS$648.93k0.024%
$ 26.2k
Daniel Vitt
CEO & Director5.6yrsUS$1.21m0.42%
$ 448.5k
Barclay Phillips
Lead Independent Director5yrsUS$99.16k0.088%
$ 94.7k
Tamar Howson
Independent Director5.1yrsUS$75.97k0.088%
$ 94.7k
Jorg Neermann
Independent Director5.6yrsUS$82.95k0.11%
$ 119.0k
Paul Utz
Member of Scientific Medical Advisory Board4yrsデータなしデータなし
Bruce Sands
Member of Scientific Medical Advisory Board4yrsデータなしデータなし
Fred Lublin
Member of Scientific Medical Advisory Board4yrsデータなしデータなし
Richard Rudick
Independent Director1.6yrsUS$95.70k0%
$ 0
Simona Skerjanec
Directorless than a yearデータなしデータなし
Monika Tornsen
Independent Director2.3yrsUS$79.67k0.041%
$ 43.9k

4.0yrs

平均在職期間

58.5yo

平均年齢

経験豊富なボード: IMUXの 取締役会 は 経験豊富 であると考えられます ( 4年の平均在任期間)。